A. Koul

579 total citations
6 papers, 445 citations indexed

About

A. Koul is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, A. Koul has authored 6 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in A. Koul's work include Tuberculosis Research and Epidemiology (3 papers), Cancer therapeutics and mechanisms (2 papers) and Antibiotic Resistance in Bacteria (2 papers). A. Koul is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), Cancer therapeutics and mechanisms (2 papers) and Antibiotic Resistance in Bacteria (2 papers). A. Koul collaborates with scholars based in United States, South Africa and India. A. Koul's co-authors include Koen Andries, Sven Hoffner, Dan I. Andersson, Peter Verhasselt, Emma Huitric, Jenny Allen, Thuli Mthiyane, R. F. Patientia, Roxana Rustomjee and Tine De Marez and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, European Respiratory Journal and Médecine et Maladies Infectieuses.

In The Last Decade

A. Koul

6 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Koul United States 4 370 303 142 101 52 6 445
Mariama C. Maiga United States 9 280 0.8× 168 0.6× 169 1.2× 50 0.5× 62 1.2× 10 384
Norio Doi Japan 10 256 0.7× 199 0.7× 157 1.1× 53 0.5× 56 1.1× 20 389
Elizabeth J. Brooks United States 11 343 0.9× 270 0.9× 129 0.9× 75 0.7× 34 0.7× 11 526
Navisha Dookie South Africa 9 316 0.9× 249 0.8× 110 0.8× 102 1.0× 31 0.6× 13 409
Joanna C. Evans South Africa 12 350 0.9× 274 0.9× 225 1.6× 106 1.0× 40 0.8× 19 481
Mel Spigelman United States 6 272 0.7× 171 0.6× 142 1.0× 70 0.7× 24 0.5× 11 376
R Lepe Chile 2 345 0.9× 265 0.9× 83 0.6× 133 1.3× 36 0.7× 4 431
Marina Makarova Russia 10 239 0.6× 219 0.7× 80 0.6× 73 0.7× 51 1.0× 23 335
Carmen A. Molina-Torres Mexico 11 208 0.6× 202 0.7× 74 0.5× 54 0.5× 25 0.5× 25 321
Alessandro Mustazzolu Italy 9 273 0.7× 232 0.8× 141 1.0× 54 0.5× 83 1.6× 14 373

Countries citing papers authored by A. Koul

Since Specialization
Citations

This map shows the geographic impact of A. Koul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Koul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Koul more than expected).

Fields of papers citing papers by A. Koul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Koul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Koul. The network helps show where A. Koul may publish in the future.

Co-authorship network of co-authors of A. Koul

This figure shows the co-authorship network connecting the top 25 collaborators of A. Koul. A scholar is included among the top collaborators of A. Koul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Koul. A. Koul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Roymans, Dirk, Sandrine Vendeville, A. Koul, Pierre Raboisson, & Nacer Lounis. (2015). CO-19 – JNJ-53718678: un composé actif contre le virus respiratoire syncitial. Archives de Pédiatrie. 22(5). 215–215. 1 indexed citations
2.
Singh, Randhir, et al.. (2011). Clinico-hematobiochemical studies in equines infected with T. evansi.. Veterinary Practitioner. 12(2). 142–147. 1 indexed citations
3.
Olszewska, Wieslawa, Gabriela Ispas, Corinna Schnoeller, et al.. (2010). Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. European Respiratory Journal. 38(2). 401–408. 42 indexed citations
4.
Lounis, Nacer, Jérôme Guillemont, Nicolas Véziris, et al.. (2009). R207910 (TMC207) : un nouvel antibiotique pour le traitement de la tuberculose. Médecine et Maladies Infectieuses. 40(7). 383–390. 19 indexed citations
5.
Huitric, Emma, Peter Verhasselt, A. Koul, et al.. (2009). Rates and Mechanisms of Resistance Development inMycobacterium tuberculosisto a Novel Diarylquinoline ATP Synthase Inhibitor. Antimicrobial Agents and Chemotherapy. 54(3). 1022–1028. 158 indexed citations
6.
Rustomjee, Roxana, Andreas H. Diacon, Jenny Allen, et al.. (2008). Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy. 52(8). 2831–2835. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026